Stock Information
Travere Therapeutics Inc (TVTX)
Ticker Symbol: TVTX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $4,013.43 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -0.2666
Revenue (TTM): $5.84 M
Dividend Yield: N/A%
ROE: -26.79%
Latest News
-
Travere Therapeutics Receives Notice of Allowance from the U.S. Patent and Trademark Office for U.S. Patent Application Directed to Certain Methods of Using FILSPARI® (sparsentan) in IgA Nephropathy
Wed, May 27, 2026 8:05 PM
-
Discover 3 Stocks That May Be Trading Below Their Estimated Value
Wed, May 27, 2026 5:38 PM
-
Travere Therapeutics Receives Notice Of Allowance From U.S. Patent And Trademark Office For Patent Titled Biphenyl Sulfonamide Compounds For The Treatment Of Kidney Diseases Or Disorders
Wed, May 27, 2026 4:15 PM
-
Dow Jones Leader Amazon, AI Stock Quanta, Monster Beverage In Or Near Buy Zones
Tue, May 26, 2026 5:25 PM
-
AstraZeneca: 8% Q1 Revenue Growth And Imfinzi/Ultomiris Trial Data Wins
Sun, May 24, 2026 9:28 AM
Key Financials
Financial data not available
